BNP and NT-proBNP in heart failure Natriuretic peptide biomarkers, particularly B-type natriuretic peptide (BNP) and its N-terminal fragment NT-proBNP, are increasingly recognized as crucial indicators in assessing cardiovascular health.Brain Natriuretic Peptide Biomarkers in Current Clinical ... These peptides are primarily used to help diagnose or rule out heart failure in individuals presenting with symptoms. Their elevated levels serve as markers of cardiac stress, providing valuable insights into the presence, severity, and prognosis of heart disease.作者：SR Motiwala·2013·被引用次数：81—Natriuretic peptides arebiological markers for HF disease—its presence, severity, and prognosis—and show unique interactions with therapeutics ... Understanding these natriuretic peptides is essential for effective cardiovascular risk prediction and management.
Natriuretic peptides are a family of hormones produced by the heart muscle in response to stretching and increased pressure. The most clinically relevant among these are atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP). BNP, synthesized as an inactive precursor protein, is cleaved into biologically active BNP and an inactive N-terminal fragment, NT-proBNP. Both BNP and NT-proBNP are released into the bloodstream when the heart is under strain, making them sensitive biomarkers for detecting cardiac dysfunction作者：ML Novack·2023·被引用次数：38—Natriuretic peptides arekey proteins that improve and regulate circulation. These proteins are essential for acting on blood vessels, ....
The primary application of natriuretic peptide testing lies in the diagnosis of heart failure (HF). Elevated levels of BNP and NT-proBNP are strong indicators of increased cardiac workload and impaired pumping function. For patients presenting with symptoms like shortness of breath, fatigue, and swelling, these biomarkers can help differentiate between cardiac and non-cardiac causes of these symptoms. A normal BNP or NT-proBNP level can effectively rule out heart failure, while significantly elevated levels strongly suggest its presence. This diagnostic utility makes natriuretic peptide testing a cornerstone in the evaluation of acute heart failure and chronic heart conditions2025年10月14日—Brain natriuretic peptide (BNP) and its inactive N-terminal fragment, NT-proBNP, are serum biomarkers with key roles in the management of ....
Beyond diagnosis, natriuretic peptide biomarkers are invaluable for assessing the severity of heart failure and predicting patient outcomesBrain Natriuretic Peptide Biomarkers in Current Clinical .... Higher concentrations of BNP and NT-proBNP are associated with a poorer prognosis, indicating a greater risk of hospitalization, cardiovascular events, and mortality. This prognostic information allows clinicians to stratify patients based on their risk level and tailor treatment strategies accordingly. For instance, individuals with very high NT-proBNP levels may require more aggressive management and closer monitoring.2016年7月16日—Natriuretic peptides (NPs)have become increasingly important markersfor evaluation of the dyspneic patient and treatment of CHF.
While several natriuretic peptides exist, BNP and NT-proBNP are the most widely used and studied in clinical practice.Brain Natriuretic Peptide Biomarkers in Current Clinical ...
BNP is a peptide hormone released by the ventricles of the heart in response to increased ventricular stretch and pressure.2025年1月7日—Natriuretic Peptides ·increased BNP and NT-proBNP levels are markers of cardiac stressbut may be elevated in settings not related to heart ... It plays a crucial role in regulating blood pressure, fluid balance, and cardiac function by promoting vasodilation, natriuresis (excretion of sodium), and diuresis (increased urine production). Elevated BNP levels are a direct reflection of the heart's stress response作者：EA El-Shorbagy·2025·被引用次数：5—Aim: This literature review aims to look atBNP as a biomarkerto monitor and detect cardiotoxic effects in patients who are getting treatments that are known ....
NT-proBNP is a biologically inactive fragment derived from the same precursor molecule as BNP作者：A Clerico·2016·被引用次数：19—Several studies indicated thatB-type natriuretic peptide (BNP) assayis able to detect patients even in the early phases of heart failure (HF), when the .... It has a longer half-life in circulation compared to BNP, which can be advantageous in certain clinical scenarios. Both BNP and NT-proBNP levels correlate with the degree of cardiac strain and are used interchangeably or complementarily in the assessment of heart failureNatriuretic Peptides as Biomarkers: Narrative Review ... - PMC. The choice between BNP and NT-proBNP often depends on laboratory availability and specific clinical guidelines.
While heart failure diagnosis and prognosis remain the primary domain for natriuretic peptide biomarkers, their utility extends to other cardiovascular conditions and even beyond.
Emerging research suggests that natriuretic peptides can outperform other biomarkers in predicting cardiovascular risk, particularly in individuals with conditions like diabetes. Elevated levels may indicate subclinical cardiac dysfunction or increased susceptibility to cardiovascular events, even in the absence of overt heart failure symptoms2024年8月16日—Currently,NPs are widely regarded as the most reliable and widely accepted biomarkerfor diagnosing acute HF. The peptides under consideration ....
Natriuretic peptides serve as excellent markers for monitoring a patient's response to heart failure therapies. A decrease in BNP or NT-proBNP levels following treatment typically indicates an improvement in cardiac function and a better prognosis. This allows clinicians to assess the effectiveness of medications and interventions and make necessary adjustments to the treatment plan.作者：M Samad·2023·被引用次数：61—ANP and BNP are the most relevant NPs as biomarkersfor the diagnosis and prognosis of heart failure and underlying cardiovascular diseases.
Studies have explored the role of natriuretic peptides in various other conditions, including pulmonary hypertension, atrial fibrillation, and even in detecting cardiotoxic effects from certain cancer treatmentsB-Type Natriuretic Peptide (BNP) Test: Normal Levels & Purpose. Furthermore, some research indicates associations between natriuretic peptide levels and conditions like type 2 diabetes, suggesting a broader role in metabolic and cardiovascular health.
Interpreting BNP and NT-proBNP test results requires careful consideration of the patient's clinical presentation, symptoms, and other relevant medical factors. Specific cutoff values are used to guide diagnosis and risk stratification, but these can vary depending on the assay used and the patient population.作者：D Harpaz·2020·被引用次数：25—They concluded thatplasma BNP can be a useful biomarkerfor predicting early recurrent stroke events during hospitalization in cardioembolic stroke patients. A ... For example, BNP levels may be elevated in individuals with kidney dysfunction, obesity, or advanced age, which needs to be factored into the interpretation.
Standard reference ranges for BNP and NT-proBNP are established, but these are general guidelines.Monitoring of BNP cardiac biomarker with major emphasis ... Clinicians rely on these ranges in conjunction with a comprehensive clinical evaluation. A BNP level below a certain threshold (e.Biomarkers in heart failure: a focus on natriuretic peptidesg.作者：M Samad·2023·被引用次数：61—ANP and BNP are the most relevant NPs as biomarkersfor the diagnosis and prognosis of heart failure and underlying cardiovascular diseases., <100 pg/mL) often suggests the absence of heart failure, while levels significantly above this (e.g., >400 pg/mL) strongly point towards its presence. NT-proBNP ranges are typically higher, with thresholds often around 300 pg/mL for younger individuals and increasing with age.A review of biosensors for the detection of B-type ...
While highly valuable, natriuretic peptide tests are not without limitations. As mentioned, factors like age, kidney function, and obesity can influence levels. Moreover, elevated BNP and NT-proBNP can occur in conditions other than heart failure, such as pulmonary embolism or sepsis, necessitating a thorough differential diagnosis. The dynamic nature of these biomarkers means that serial measurements can provide more valuable information than a single test.
In conclusion, natriuretic peptide biomarkers, particularly BNP and NT-proBNP, are indispensable tools in modern cardiology. Their ability to aid in the diagnosis, prognosis, and management of heart failure, as well as their emerging roles in cardiovascular risk prediction and treatment monitoring, underscore their critical importance in safeguarding cardiovascular health.
Join the newsletter to receive news, updates, new products and freebies in your inbox.